Ken Momosaki

471 total citations
22 papers, 286 citations indexed

About

Ken Momosaki is a scholar working on Physiology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Ken Momosaki has authored 22 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 10 papers in Molecular Biology and 5 papers in Clinical Biochemistry. Recurrent topics in Ken Momosaki's work include Lysosomal Storage Disorders Research (11 papers), Metabolism and Genetic Disorders (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Ken Momosaki is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Metabolism and Genetic Disorders (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Ken Momosaki collaborates with scholars based in Japan and United Kingdom. Ken Momosaki's co-authors include Kimitoshi Nakamura, Jun Kido, Fumio Endo, Keishin Sugawara, Shinichiro Yoshida, Shirou Matsumoto, Shinichi Hirose, Hiroshi Mitsubuchi, Takahito Inoue and Yasuhiro Arai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Orphanet Journal of Rare Diseases.

In The Last Decade

Ken Momosaki

22 papers receiving 282 citations

Peers

Ken Momosaki

PHYSI

RHEUM

GENET

EPIDE

Mohammad Arif Hossain Japan

Cate Walsh Vockley United States

Juan Francisco Cabello Chile

François Eyskens Belgium

Vladimı́r Bzdúch Slovakia

Suresh Vijay United Kingdom

Paula Frassinetti Vasconcelos de Medeiros Brazil

Marie Jackson United Kingdom

Jessica de Ruijter Netherlands

C. Whitehouse United Kingdom

Mohammad Arif Hossain Japan

Ken Momosaki

196 ×1.2

PHYSI

113 ×1.1

42 ×0.5

RHEUM

34 ×0.5

GENET

79 ×1.4

EPIDE

Citations per year, relative to Ken Momosaki Ken Momosaki (= 1×) peers Mohammad Arif Hossain

Countries citing papers authored by Ken Momosaki

Since Specialization

Citations

This map shows the geographic impact of Ken Momosaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Momosaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Momosaki more than expected).

Fields of papers citing papers by Ken Momosaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Momosaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Momosaki. The network helps show where Ken Momosaki may publish in the future.

Co-authorship network of co-authors of Ken Momosaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Momosaki. A scholar is included among the top collaborators of Ken Momosaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Momosaki. Ken Momosaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Momosaki, Ken, et al.. (2022). Severe metabolic acidosis with cardiac involvement in DNM1L‐related mitochondrial encephalopathy. Pediatrics International. 64(1). e14879–e14879. 1 indexed citations

Kido, Jun, Keishin Sugawara, Ken Momosaki, et al.. (2021). Current status of newborn screening for Pompe disease in Japan. Orphanet Journal of Rare Diseases. 16(1). 15 indexed citations

Kido, Jun, Ken Momosaki, Shiro Ozasa, et al.. (2021). Mitochondrial DNA depletion syndrome with a mutation in SLC25A4 developing epileptic encephalopathy: A case report. Brain and Development. 44(1). 56–62. 6 indexed citations

Sawada, Jun, Naoki Nakagawa, Tsukasa Saito, et al.. (2021). Characteristics of Neurological Symptoms in Adult Japanese Patients with Fabry Disease. Internal Medicine. 60(12). 1819–1826. 8 indexed citations

Kido, Jun, Shinichiro Yoshida, Keishin Sugawara, et al.. (2020). Newborn screening for Fabry disease in the western region of Japan. Molecular Genetics and Metabolism Reports. 22. 100562–100562. 46 indexed citations

Kido, Jun, et al.. (2020). Effect of Flunarizine on Alternating Hemiplegia of Childhood in a Patient with the p.E815K Mutation in ATP1A3: A Case Report. SHILAP Revista de lepidopterología. 12(3). 299–306. 2 indexed citations

Yoshida, Shinichiro, Jun Kido, Ken Momosaki, et al.. (2020). Fabry disease screening in high-risk populations in Japan: a nationwide study. Orphanet Journal of Rare Diseases. 15(1). 220–220. 11 indexed citations

Momosaki, Ken, Jun Kido, Shirou Matsumoto, Shiro Ozasa, & Kimitoshi Nakamura. (2020). Adrenocorticotropic Hormone Therapy Improved Spasms and Sleep Disturbance in Smith–Magenis Syndrome: A Case Report. Pediatric Reports. 12(3). 72–76. 4 indexed citations

Nakagawa, Naoki, Jun Sawada, Naka Sakamoto, et al.. (2019). High-risk screening for Anderson–Fabry disease in patients with cardiac, renal, or neurological manifestations. Journal of Human Genetics. 64(9). 891–898. 16 indexed citations

10.

Momosaki, Ken, Jun Kido, Shinichiro Yoshida, et al.. (2019). Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients. Journal of Human Genetics. 64(8). 741–755. 32 indexed citations

11.

Momosaki, Ken, Jun Kido, Atsuo Taniguchi, et al.. (2019). The Effect of S-Adenosylmethionine Treatment on Neurobehavioral Phenotypes in Lesch-Nyhan Disease: A Case Report. SHILAP Revista de lepidopterología. 11(3). 256–264. 8 indexed citations

12.

Kawashima, Y., Kazuya Itomi, Ken Momosaki, et al.. (2018). Natural histories of patients with Wolf‐Hirschhorn syndrome derived from variable chromosomal abnormalities. Congenital Anomalies. 59(5). 169–173. 5 indexed citations

13.

Kido, Jun, Ken Momosaki, Yosuke Suzuki, et al.. (2018). Neonatal methionine adenosyltransferase I/III deficiency with abnormal signal intensity in the central tegmental tract. Brain and Development. 41(4). 382–388. 8 indexed citations

14.

Momosaki, Ken, Jun Kido, Shirou Matsumoto, et al.. (2018). High-risk screening for Gaucher disease in patients with neurological symptoms. Journal of Human Genetics. 63(6). 717–721. 7 indexed citations

15.

Nakagawa, Naoki, Naka Sakamoto, Toshiharu Takeuchi, et al.. (2018). Unexpectedly High Prevalence of Coronary Spastic Angina in Patients With Anderson-Fabry Disease. Circulation Journal. 83(2). 481–484. 13 indexed citations

16.

Kido, Jun, Shirou Matsumoto, Ken Momosaki, et al.. (2017). Liver transplantation may prevent neurodevelopmental deterioration in high‐risk patients with urea cycle disorders. Pediatric Transplantation. 21(6). 18 indexed citations

17.

Mori, Hiroko, Ken Momosaki, Jun Kido, et al.. (2016). Amelioration by glycine of brain damage in neonatal rat brain following hypoxia–ischemia. Pediatrics International. 59(3). 321–327. 4 indexed citations

18.

Kido, Jun, Shirou Matsumoto, Ken Momosaki, et al.. (2016). Plasma exchange and chelator therapy rescues acute liver failure in Wilson disease without liver transplantation. Hepatology Research. 47(4). 359–363. 17 indexed citations

19.

Sawada, Jun, Takayuki Katayama, Tsukasa Saito, et al.. (2015). A Sporadic Case of Fabry Disease Involving Repeated Fever, Psychiatric Symptoms, Headache, and Ischemic Stroke in an Adult Japanese Woman. Internal Medicine. 54(23). 3069–3074. 8 indexed citations

20.

Shimada, Shino, Nobuhiko Okamoto, Masahiro Ito, et al.. (2012). MECP2 duplication syndrome in both genders. Brain and Development. 35(5). 411–419. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact